These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28657769)

  • 21. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial.
    Chen J; Geng L; Song X; Li H; Giordan N; Liao Q
    J Sex Med; 2013 Jun; 10(6):1575-84. PubMed ID: 23574713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of nettle vaginal cream on subjective symptoms of vaginal atrophy in postmenopausal women.
    Karimi FZ; Nazari N; Rakhshandeh H; Mazloum SR
    Eur J Obstet Gynecol Reprod Biol; 2023 Jun; 285():41-45. PubMed ID: 37044017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of non-hormonal remedies for vaginal dryness: open, prospective, randomized trial.
    Stute P; May TW; Masur C; Schmidts-Winkler IM
    Climacteric; 2015; 18(4):582-9. PubMed ID: 25845406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy.
    Alvisi S; Lami A; Baldassarre M; Lenzi J; Mancini I; Seracchioli R; Meriggiola MC
    J Sex Med; 2022 May; 19(5):761-770. PubMed ID: 35370104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing postmenopausal vaginal atrophy. Vaginal dryness is one of the most irritating symptoms of menopause. Here are some ways to relieve it.
    Harv Womens Health Watch; 2010 Mar; 17(7):4-5. PubMed ID: 20480969
    [No Abstract]   [Full Text] [Related]  

  • 26. Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical Trial.
    Melisko ME; Goldman ME; Hwang J; De Luca A; Fang S; Esserman LJ; Chien AJ; Park JW; Rugo HS
    JAMA Oncol; 2017 Mar; 3(3):313-319. PubMed ID: 27832260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaginal hormone-free moisturising cream is not inferior to an estriol cream for treating symptoms of vulvovaginal atrophy: Prospective, randomised study.
    Garcia de Arriba S; Grüntkemeier L; Häuser M; May TW; Masur C; Stute P
    PLoS One; 2022; 17(5):e0266633. PubMed ID: 35551533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom.
    Kroll R; Archer DF; Lin Y; Sniukiene V; Liu JH
    Menopause; 2018 Feb; 25(2):133-138. PubMed ID: 28926514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial.
    Archer DF; Goldstein SR; Simon JA; Waldbaum AS; Sussman SA; Altomare C; Zhu J; Yoshida Y; Schaffer S; Soulban G
    Menopause; 2019 Jan; 26(6):611-621. PubMed ID: 30694917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TX-004HR Improves Sexual Function as Measured by the Female Sexual Function Index in Postmenopausal Women With Vulvar and Vaginal Atrophy: The REJOICE Trial.
    Kingsberg SA; Derogatis L; Simon JA; Constantine GD; Graham S; Bernick B; Gasper G; Mirkin S
    J Sex Med; 2016 Dec; 13(12):1930-1937. PubMed ID: 27692842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial.
    Diem SJ; Guthrie KA; Mitchell CM; Reed SD; Larson JC; Ensrud KE; LaCroix AZ
    Menopause; 2018 Oct; 25(10):1086-1093. PubMed ID: 29738424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An effective non-hormonal option with high tolerability for mild to moderate symptoms of vaginal dryness associated with menopause.
    Eichler S; Panz M; Harder A; Masur C; Häuser M; Wiesche ESZ
    Maturitas; 2024 Jul; 185():107978. PubMed ID: 38583316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polycarbophil vaginal moisturizing gel versus hyaluronic acid gel in women affected by vaginal dryness in late menopausal transition: A prospective randomized trial.
    Cagnacci A; Barattini DF; Casolati E; Pecoroni A; Mangrella M; Patrascu LC
    Eur J Obstet Gynecol Reprod Biol; 2022 Mar; 270():239-245. PubMed ID: 35131532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy.
    Parsons A; Merritt D; Rosen A; Heath H; Siddhanti S; Plouffe L;
    Obstet Gynecol; 2003 Feb; 101(2):346-52. PubMed ID: 12576260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
    Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
    Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial.
    Fernandes T; Costa-Paiva LH; Pedro AO; Baccaro LF; Pinto-Neto AM
    Menopause; 2016 Jul; 23(7):792-8. PubMed ID: 27116462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and preliminary efficacy of two vaginal gel formulations of ultra-low-dose estriol in postmenopausal women.
    Delgado JL; Estevez J; Radicioni M; Loprete L; Moscoso Del Prado J; Nieto Magro C
    Climacteric; 2016 Apr; 19(2):172-80. PubMed ID: 26786399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Open, non-controlled clinical studies to assess the efficacy and safety of a medical device in form of gel topically and intravaginally used in postmenopausal women with genital atrophy.
    Morali G; Polatti F; Metelitsa EN; Mascarucci P; Magnani P; Marrè GB
    Arzneimittelforschung; 2006; 56(3):230-8. PubMed ID: 16618016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical treatment of vaginal dryness with a non-hormonal cream in women undergoing breast cancer treatment - An open prospective multicenter study.
    Chatsiproios D; Schmidts-Winkler IM; König L; Masur C; Abels C
    PLoS One; 2019; 14(1):e0210967. PubMed ID: 30677065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TX-004HR clinically improves symptoms of vulvar and vaginal atrophy in postmenopausal women.
    Simon JA; Kagan R; Archer DF; Constantine GD; Bernick B; Graham S; Mirkin S
    Climacteric; 2019 Aug; 22(4):412-418. PubMed ID: 30862193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.